Obesity is associated with chronic low-grade
inflammation and oxidative stress that blunt
insulin response in its target tissues, leading to
insulin resistance (IR). IR is a characteristic feature of
type 2 diabetes. Skeletal muscle is responsible for 75% of total
insulin-dependent
glucose uptake; consequently, skeletal muscle IR is considered to be the primary defect of systemic IR development. Interestingly, some obese people stay
insulin-sensitive and metabolically healthy. With the aim of understanding this difference and identifying the mechanisms responsible for
insulin sensitivity maintenance/IR development during
obesity, we explored the role of the latent
endoribonuclease (
RNase L) in skeletal muscle cells.
RNase L is a regulator of innate immunity, of
double-stranded RNA sensors and of
toll-like receptor (TLR) 4 signaling. It is regulated during
inflammation by
interferons and its activity is dependent on its binding to 2-5A, an
oligoadenylate synthesized by
oligoadenylate synthetases (OAS). Increased expression of
RNase L or downregulation of its inhibitor (RLI) improved
insulin response in mouse myogenic C2C12 cells and in primary human myotubes from normal-weight subjects treated with
palmitate, a saturated
free fatty acid (FFA) known to induce
inflammation and oxidative stress via TLR4 activation. While
RNase L and RLI levels remained unchanged, OAS level was decreased in primary myotubes from
insulin-resistant obese subjects (OB-IR) compared with myotubes from
insulin-sensitive obese subjects (OB-IS). TLR3 and mitochondrial
manganese superoxide dismutase (MnSOD) were also underexpressed in OB-IR myotubes. Activation of
RNase L by 2-5A transfection allowed to restore
insulin response, OAS, MnSOD and TLR3 expression in OB-IR myotubes. Due to low expression of OAS, OB-IR myotubes present a defect in
RNase L activation and TLR3 regulation. Consequently, MnSOD level is low and
insulin sensitivity is reduced. These results support that
RNase L activity limits FFA/
obesity-induced impairment of
insulin response in muscle cells via TLR3 and MnSOD expression.